Contribution of SHANK3 mutations to autism spectrum disorder.

Mutations in SHANK3, which encodes a synaptic scaffolding protein, have been described in subjects with an autism spectrum disorder (ASD). To assess the quantitative contribution of SHANK3 to the pathogenesis of autism, we determined the frequency of DNA sequence and copy-number variants in this gene in 400 ASD-affected subjects ascertained in Canada. One de novo mutation and two gene deletions were discovered, indicating a contribution of 0.75% in this cohort. One additional SHANK3 deletion was characterized in two ASD-affected siblings from another collection, which brings the total number of published mutations in unrelated ASD-affected families to seven. The combined data provide support that haploinsufficiency of SHANK3 can cause a monogenic form of autism in sufficient frequency to warrant consideration in clinical diagnostic testing.

[1]  Thomas C. Südhof,et al.  Neuroligins Determine Synapse Maturation and Function , 2006, Neuron.

[2]  S. Scherer,et al.  Severe expressive-language delay related to duplication of the Williams-Beuren locus. , 2005, The New England journal of medicine.

[3]  Eric Fombonne,et al.  Pervasive developmental disorders in preschool children: confirmation of high prevalence. , 2005, The American journal of psychiatry.

[4]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[5]  Eckart D Gundelfinger,et al.  An Architectural Framework That May Lie at the Core of the Postsynaptic Density , 2006, Science.

[6]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[7]  A. Monaco,et al.  A forkhead-domain gene is mutated in a severe speech and language disorder , 2001, Nature.

[8]  Nigel P. Carter,et al.  Accurate and reliable high-throughput detection of copy number variation in the human genome. , 2006, Genome research.

[9]  C. Corsello,et al.  Combining information from multiple sources in the diagnosis of autism spectrum disorders. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[11]  P. Worley,et al.  Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons , 2005, The Journal of Neuroscience.

[12]  L. Hudson,et al.  Myt1 family recruits histone deacetylase to regulate neural transcription , 2005, Journal of neurochemistry.

[13]  D. Gerlier,et al.  Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. , 2005, Journal of virological methods.

[14]  Junjun Zhang,et al.  Human Chromosome 7: DNA Sequence and Biology , 2003, Science.

[15]  H. Engeland,et al.  Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism , 2006, Molecular Psychiatry.

[16]  T. Bourgeron,et al.  Searching for ways out of the autism maze: genetic, epigenetic and environmental clues , 2006, Trends in Neurosciences.

[17]  S. Klauck,et al.  Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism , 2006, Molecular Psychiatry.

[18]  O. Steinlein,et al.  Benign familial neonatal convulsions: Always benign? , 2007, Epilepsy Research.

[19]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[20]  Edwin H Cook,et al.  Autism as a paradigmatic complex genetic disorder. , 2004, Annual review of genomics and human genetics.

[21]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[22]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[23]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[24]  Thomas Bourgeron,et al.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.

[25]  H. McDermid,et al.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.

[26]  Shamil R Sunyaev,et al.  Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.

[27]  T. Boeckers,et al.  Proline-Rich Synapse-Associated Protein-1/Cortactin Binding Protein 1 (ProSAP1/CortBP1) Is a PDZ-Domain Protein Highly Enriched in the Postsynaptic Density , 1999, The Journal of Neuroscience.

[28]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[29]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[30]  L. Feuk,et al.  Structural variants: changing the landscape of chromosomes and design of disease studies. , 2006, Human molecular genetics.

[31]  D. Pinto,et al.  A Novel Splicing Mutation in KCNQ2 in a Multigenerational Family with BFNC Followed for 25 Years , 2006, Epilepsia.

[32]  Nils Brose,et al.  The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin , 2004, Neuropharmacology.

[33]  R. Borgatti,et al.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. , 2001, American journal of human genetics.

[34]  S. Scherer,et al.  Molecular Cytogenetics of Autism , 2004 .

[35]  L. Jocelyn,et al.  Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype , 2000, Clinical genetics.

[36]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[37]  R Redon,et al.  Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders , 2006, Journal of Medical Genetics.